Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

4 Stocks To Watch: ADXS, EXEL, NVAX, XNCR

Published 08/04/2016, 06:25 AM
Updated 07/09/2023, 06:31 AM

It was a nice rally back on Wall Street on Wednesday. We have a lot of stocks that are doing well, so let’s take a look at them and see how they are doing.

Advaxis, Inc. (NASDAQ:ADXS) was the super star on Wednesday, up 2.61 to 13.69, or 23 1/2%, on 5.7 million shares, and reaching as high as 14.24. That was a big day for this stock. With 12.9 days to cover, even though it’s at resistance, there’s a possibility that it could extend to the 16-17-18 range. I don’t know if it will make it, but if it pulls back and consolidates nicely, it could get up to the next level. It has 12.9 days to cover.

Exelixis, Inc. (NASDAQ:EXEL) has a phenomenal trend, a really tight rising channel. On Wednesday, it was up 24 cents to 9.39, or 2.6%, on 7.3 million shares. It reversed on Wednesday and then in afterhours it was trading low again. Even though there is resistance in this area, it wouldn’t surprise me if it ran up to the 11-12 area. It has 7 days to cover.

Novavax, Inc. (NASDAQ:NVAX), a swing trade of ours, has been consolidating for a couple weeks, and on Wednesday it popped 42 cents to 7.61, or 5.84%, on 4.3 million shares. It looks like it’s ready to test the 8-8 1/4 range, and then 9 1/2. It has 12.2 days to cover.

Xencor, Inc. (NASDAQ:XNCR), one of our swing trades, did great on Wednesday, up 1.88 to 21.16, or 9.75%, on 541,100 shares traded. It broke out of a wedge and took off running, actually tagging 21.81, which is my target. The secondary target is 24. We’ll see if we get a follow-through, and then consolidate. It has 5.35 days to cover.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks on the long side included Advaxis, Inc. (ADXS), Amkor Technology, Inc. (NASDAQ:AMKR), Cempra, Inc. (NASDAQ:CEMP), Cemtrex Inc. (NASDAQ:CETX), CaesarStone Sdot-Yam Ltd. (NASDAQ:CSTE), 3D Systems Corporation (NYSE:DDD), Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), Etsy, Inc. (NASDAQ:ETSY), Exact Sciences Corporation (NASDAQ:EXAS), Exelixis, Inc. (EXEL), Fitbit Inc. (NYSE:FIT), INSYS Therapeutics, Inc. (NASDAQ:INSY), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU), MeetMe Inc. (NASDAQ:MEET), NeoPhotonics Corporation (NYSE:NPTN), Novavax, Inc. (NVAX), Oclaro, Inc. (NASDAQ:OCLR), Ocean Power Technologies, Inc. (NASDAQ:OPTT), Aratana Therapeutics, Inc. (NASDAQ:PETX), Primo Water Corporation (NASDAQ:PRMW), Shopify Inc. (NYSE:SHOP), U.S. Silica Holdings, Inc. (NYSE:SLCA), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), and Xencor, Inc. (XNCR).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.